Difference in treatment for metastatic bone tumors due to differences in opinion among departments - The role of medical teams for metastatic bone tumors

Daisuke Kikuchi, Toshiro Iizuka, Naohisa Yahagi, Hirotaka Maruno, Atushi Okazaki, Yusuke Takeda, Seizou Yamamoto, Hidetaka Kawabata, Masahiro Hayashi, Kazuma Kishi

研究成果: Article査読

抄録

Few experts can deal appropriately with metastatic bone tumors in the present situation. We developed a questionnaire about zoledronic acid for doctors with several specialties, and analyzed the differences in treatment strategy among various doctors retrospectively. Breast surgeons, have used zoledronic acid appropriately based on accurate knowledge, but it has been used inappropriately by doctors of other specialties due to lack of knowledge. Development of new treatment for metastatic bone tumors is awaited, but there is a possibility of inappropriate use as with zoledronic acid because of lack of knowledge and experience. So a medical team is necessary to provide the most recent knowledge of metastatic bone tumor and to enlighten other doctors.

本文言語English
ページ(範囲)473-477
ページ数5
ジャーナルJapanese Journal of Cancer and Chemotherapy
37
3
出版ステータスPublished - 2010 3 6
外部発表はい

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

フィンガープリント 「Difference in treatment for metastatic bone tumors due to differences in opinion among departments - The role of medical teams for metastatic bone tumors」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル